European $45 Billion Weight Loss Management Market Outlook to 2029: Rise of Personalised Nutrition and Wellness, Data-Driven Personalisation, Increasing Obesity Rates
May 07, 2024 05:07 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Europe Weight Loss Management Market Outlook, 2029" report has been added to ResearchAndMarkets.com's offering.Europe Weight Loss and Weight Management...
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
May 02, 2024 08:30 ET
|
Elevai Labs Inc.
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
May 01, 2024 09:00 ET
|
Elevai Labs Inc.
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
UMeWorld Limited Updates Investors on Acquisition, Uplist and Relocation
April 30, 2024 08:00 ET
|
UMeWorld Limited
MIAMI, April 30, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is thankful to have the opportunity to update existing and future shareholders of the company operations and 2024 strategy...
Weight Loss Drugs Market Trends Analysis 2018-2023 and Opportunities Forecast 2024-2033 Featuring Pfizer, Roche, Merck & Co, AbbVie, and Novartis
April 24, 2024 04:12 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The weight loss drugs market size has...
Enhanced Inventory Management Solutions to Meet Rising E-Commerce Demand
April 23, 2024 08:05 ET
|
LadyBug Resource Group, Inc.
Enhanced Inventory Management Solutions to Meet Rising E-Commerce Demand
Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy)
April 23, 2024 05:18 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact...
United States Telehealth Weight Loss Market Report 2024: Surge in Telehealth Weight Loss Programs Amidst GLP-1 Medications Boom - Analysis, Forecasts, and Consolidation Insights for 2025
April 17, 2024 03:13 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth...
More Acquisitions on Horizon for Ladybug’s Growing E-Commerce Revenue Model
April 16, 2024 08:05 ET
|
LadyBug Resource Group, Inc.
MORE ACQUISITIONS ON HORIZON FOR LADYBUG’S GROWING E-COMMERCE REVENUE MODEL
New Nextech Med Spa for Wellness and Weight Loss Software Increases Average Patient Encounter Revenue by 70%
April 10, 2024 13:00 ET
|
Nextech Systems, Inc.
The new Nextech Med Spa for Wellness and Weight Loss empowers businesses with features like eRx and labs to easily expand their services and drive revenue.